News

For DHCS MAT Expansion Project news, please visit the DHCS website.
Treatment services can be provided in a variety of settings and accessed through a large network of physicians and treatment facilities, including many primary care physicians.
For DHCS MAT Expansion Project news, please visit the DHCS website.
SACRAMENTO — California, through the Department of Health Care Services (DHCS), today announced it will expand Medication Assisted Treatment (MAT) to jails and drug courts. The $2.9 million funding announced ...
The Department of Health Care Services (DHCS) is releasing a Request for Applications (RFA) to support California non-profit organizations to expand access and utilization of behavioral health recovery services through ...
SACRAMENTO – As part of Governor Gavin Newsom’s $1 billion Master Plan for Tackling the Fentanyl and Opioid Crisis, the Department of Health Care Services (DHCS) has awarded $12.1 million to 54 ...
SACRAMENTO – As part of Governor Gavin Newsom’s $1 billion Master Plan for tackling the fentanyl and opioid crisis, California today awarded $5.7 million for opioid and stimulant use education ...
SACRAMENTO — The Department of Health Care Services (DHCS) today announced awards of $430 million for projects that will increase mental health and substance use disorder treatment infrastructure in 21 ...
SACRAMENTO — The Department of Health Care Services (DHCS) awarded $1.2 million to 11 organizations through the Tribal Local Opioid Coalition (TLOC). This project is funded by the State Opioid ...
SACRAMENTO — The Department of Health Care Services (DHCS) today awarded more than $7.4 million to 24 California tribal organizations through the Crisis Care Mobile Units (CCMU) program to support ...
Xylazine, or “tranq,” is animal tranquilizer that is not approved for human use. Xylazine has been increasingly found in the U.S. illicit drug supply, and studies have linked it to ...
SACRAMENTO — As part of California’s $1 billion plan to tackle the opioid epidemic, the Department of Health Care Services (DHCS) today awarded more than $12 million in grants to ...
SACRAMENTO — Californians now have a free, confidential way to find lifesaving, high-quality addiction treatment to meet their unique needs. The Department of Health Care Services (DHCS) today launched a ...
What: The Bridge Navigator Program Training Series provides education and resources to hospital teams implementing MAT programs in the acute care setting. These training events are specifically for hospitals receiving funding ...
The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, ...
This 2-hour virtual training will provide a general overview of the cultural, social, and historical factors that have had and continue to have a significant impact on the lives of American Indians and Alaska Natives (AI/ANs) families.
A one-hour clinic will be held every third Tuesday from 12-1pm (PT). The purpose of the monthly Tribal MAT ECHO™ Clinic is to support health care providers in Indian Country ...
This 2-hour virtual training will provide a general overview of the cultural, social, and historical factors that have had and continue to have a significant impact on the lives of ...
This session will help participants understand the evidence for buprenorphine and its role as medication for opioid use disorder, start patients on medication for addiction treatment (MAT) with buprenorphine, and ...
A one-hour clinic will be held every fourth Monday from 12-1pm PT. The purpose of this one-hour web training is to provide physicians, nurses, and other health care providers an ...
This 2-hour virtual training will provide a general overview of the cultural, social, and historical factors that have had and continue to have a significant impact on the lives of American Indians and Alaska Natives (AI/ANs) families.
Xylazine, also known as “tranq”, is a growing concern in our drug supply, and increases the risk of overdose when combined with fentanyl. To be effective in our response, it’s ...
The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, ...
Treatment services can be provided in a variety of settings and accessed through a large network of physicians and treatment facilities, including many primary care physicians.